BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 28933767)

  • 1. Hemin Improves Insulin Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet.
    Luan Y; Zhang F; Cheng Y; Liu J; Huang R; Yan M; Wang Y; He Z; Lai H; Wang H; Ying H; Guo F; Zhai Q
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
    Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
    Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
    Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorogenic Acid Targeting of the AKT PH Domain Activates AKT/GSK3β/FOXO1 Signaling and Improves Glucose Metabolism.
    Gao J; He X; Ma Y; Zhao X; Hou X; Hao E; Deng J; Bai G
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30249058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
    Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
    Lees EK; Krol E; Shearer K; Mody N; Gettys TW; Delibegovic M
    Metabolism; 2015 Feb; 64(2):305-14. PubMed ID: 25468142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
    Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
    Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspalathin-Enriched Green Rooibos Extract Reduces Hepatic Insulin Resistance by Modulating PI3K/AKT and AMPK Pathways.
    Mazibuko-Mbeje SE; Dludla PV; Roux C; Johnson R; Ghoor S; Joubert E; Louw J; Opoku AR; Muller CJF
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine monophosphate-activated protein kinase activity and lipogenic gene expression in high-fat diet-fed obese mice.
    Saito T; Nishida M; Saito M; Tanabe A; Eitsuka T; Yuan SH; Ikekawa N; Nishida H
    Nutr Res; 2016 Oct; 36(10):1090-1097. PubMed ID: 27865350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet.
    Choi JS; Kim H; Jung MH; Hong S; Song J
    Mol Nutr Food Res; 2010 Jul; 54(7):1004-13. PubMed ID: 20112296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
    Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
    J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity.
    Xiong Y; Chen Y; Huang X; Yang Z; Zhang J; Yu X; Fang J; Tao J; You K; Cheng Z; Tan S; Xu Y; Yuan F; Liu Y; Zhuang Y; Yang F; Li Y
    Life Sci; 2021 Mar; 268():119000. PubMed ID: 33417961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.